DEA Archived Press Releases

Press Releases before January 20, 2025
54 Results - Showing 1 to 10
PRESS RELEASE

13 Additional Defendants Charged in Fentanyl Distribution Network that Spanned from California to D.C.

WASHINGTON – Federal and local law enforcement announced the arrests of 11 more alleged members of a fentanyl drug distribution network responsible for bringing hundreds of thousands of fake Oxycodone (M30) pills from California to D.C. Today's announcement was made by DEA Administrator Anne Milgram, U.S. Attorney Matthew M. Graves...
PRESS RELEASE

DEA’s National Prescription Drug Take Day Removes Almost 600,000 Pounds of Unneeded Prescription Medications Across the Country

WASHINGTON – On Oct. 28, 2023, the community once again emptied their medicine cabinets to help dispose of old, unwanted, and expired medications. Nationwide, DEA and its law enforcement partners collected 599,897 pounds of unneeded medications at 4,675 collection sites nationwide. For more than a decade, DEA’s National Prescription Take...
PRESS RELEASE

DEA Executes Operation Bottleneck to Prevent the Diversion of Controlled Substances and Keep Communities Safe

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...
PRESS RELEASE

DEA Hosts 25th National Prescription Drug Take Back Day

WASHINGTON, DC – The Drug Enforcement Administration will host its 25th National Prescription Drug Take Back Day on Saturday, October 28, from 10 a.m. to 2 p.m. This event offers an easy, no-cost opportunity for the community to anonymously dispose of unneeded medications at nearly 5,000 local drop-off locations nationwide...
PRESS RELEASE

DEA Holds Second Annual Family Summit on Fentanyl

WASHINGTON – On September 25 and 26, the U.S. Drug Enforcement Administration hosted the second annual DEA Family Summit on Fentanyl for families from across the country who have experienced the profound loss of a child due to a drug poisoning. U.S. Attorney General Merrick B. Garland and DEA Administrator...
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day with Extended Hours for the Faces of Fentanyl Exhibit

WASHINGTON – The Drug Enforcement Administration recognizes National Fentanyl Prevention and Awareness Day by joining the dedicated voices who continue to raise awareness in an effort to prevent the fentanyl poisonings devastating families across the country. On Monday, August 21 the DEA Museum will open with extended hours from 6...
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...
PRESS RELEASE

Communities Across the Country Remove Nearly 664,000 Pounds of Unneeded Prescription Medications to Prevent Drug Misuse

WASHINGTON – On April 22, 2023, DEA and its law enforcement partners came together once again to protect our communities from prescription misuse by safely disposing of 663,725 pounds of unneeded medications at nearly 5,000 collection sites across the country. Since its inception in 2010, DEA’s bi-annual National Prescription Take...
PRESS RELEASE

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public

WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...
PRESS RELEASE

DEA Recognizes National Fentanyl Awareness Day

WASHINGTON – DEA is proud to join “Song for Charlie” and many of our valued law enforcement, public health, and non-profit partners in recognizing National Fentanyl Awareness Day. Tomorrow represents an important opportunity to remember the victims of fentanyl poisoning and educate people in our communities about the deadly threat...